TrialMedical oncology (Northwood, London, England)2014
M2-polarized macrophages contribute to the decreased sensitivity of EGFR-TKIs treatment in patients with advanced lung adenocarcinoma.
Bicheng Zhang et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
31 papers cite it
this papertrialcites it